SEPRIUM Trademark

Trademark Overview


On Thursday, September 22, 2011, a trademark application was filed for SEPRIUM with the United States Patent and Trademark Office. The USPTO has given the SEPRIUM trademark a serial number of 85428895. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 27, 2013. This trademark is owned by Glaxo Group Limited. The SEPRIUM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
seprium

General Information


Serial Number85428895
Word MarkSEPRIUM
Filing DateThursday, September 22, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 27, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2012

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 27, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events


Event DateEvent Description
Tuesday, May 28, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 27, 2013ABANDONMENT - NO USE STATEMENT FILED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 12, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 11, 2012EXTENSION 1 GRANTED
Tuesday, October 9, 2012EXTENSION 1 FILED
Thursday, October 11, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 9, 2012TEAS EXTENSION RECEIVED
Tuesday, April 24, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 28, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2012PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 7, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 6, 2012ASSIGNED TO EXAMINER
Tuesday, September 27, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 26, 2011NEW APPLICATION ENTERED IN TRAM